Companies / Switzerland
Lonza Looks To Biopharmaceuticals For Growth
August 2006 | Company Finance AlertSwiss contract manufacturing organisation (CMO) Lonza has released first half of 2006 financial results that were in line with expectations and announced that it will increasingly focus on biopharmaceuticals to remain competitive against Chinese
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
